CD38 and neoplasm: ADO is produced from the dismantling of mono- and dinucleotides (ATP and NAD+) and their byproducts (ADP, ADPR, AMP) by a set of ectoenzymes (CD39, CD38, CD203a, and CD73), of interest to both basic and clinical research because of their involvement in tumor biology and immune response.